Biological Assembly 1  

 3D View: Structure | 1D-3D View | Validation Report

Global Symmetry: Asymmetric - C1 
Global Stoichiometry: Monomer - A1 

Biological assembly 1 assigned by authors.

Macromolecule Content

• Total Structure Weight: 28.35 kDa 
• Atom Count: 2005 
• Modelled Residue Count: 255 
• Deposited Residue Count: 255 
• Unique protein chains: 1

6AMW

Abl1b Regulatory Module 'Activating' conformation

• PDB DOI: 10.2210/pdb6AMW/pdb
• BMRB: 30332

• Classification: SIGNALING PROTEIN
• Organism(s): Homo sapiens
• Expression System: Escherichia coli BL21
• Mutation(s): No 


• Deposited: 2017-08-11 Released: 2017-09-27 
• Deposition Author(s): Kalodimos, C.G., Rossi, P., Saleh, T.
• Funding Organization(s): National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)

---

Experimental Data Snapshot

• Method: SOLUTION NMR
• Conformers Calculated: 100 
• Conformers Submitted: 20 
• Selection Criteria: target function 

Literature

Atomic view of the energy landscape in the allosteric regulation of Abl kinase.

Saleh, T., Rossi, P., Kalodimos, C.G.

(2017) Nat Struct Mol Biol 24: 893-901

• PubMed: 28945248 
• DOI: 10.1038/nsmb.3470
• Primary Citation of Related Structures:  
  6AMV, 6AMW


• PubMed Abstract: 
  

The activity of protein kinases is often regulated in an intramolecular fashion by signaling domains, which feature several phosphorylation or protein-docking sites. How kinases integrate such distinct binding and signaling events to regulate their activities is unclear, especially in quantitative terms. We used NMR spectroscopy to show how structural elements within the Abl regulatory module (RM) synergistically generate a multilayered allosteric mechanism that enables Abl kinase to function as a finely tuned switch. We dissected the structure and energetics of the regulatory mechanism to precisely measure the effects of various activating or inhibiting stimuli on Abl kinase activity. The data provide a mechanistic basis explaining genetic observations and reveal a previously unknown activator region within Abl. Our findings show that drug-resistance mutations in the Abl RM exert their allosteric effect by promoting the activated state of Abl and not by decreasing the drug affinity for the kinase.

---

Organizational Affiliation: 

Department of Biochemistry, Molecular Biology & Biophysics, University of Minnesota, Minneapolis, Minnesota, USA.

Macromolecules

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
Tyrosine-protein kinase ABL1	A	255	Homo sapiens	Mutation(s): 0  Gene Names: ABL1, ABL, JTK7 EC: 2.7.10.2
UniProt & NIH Common Fund Data Resources
Find proteins for P00519 (Homo sapiens) Explore P00519  Go to UniProtKB:  P00519
PHAROS:  P00519 GTEx:  ENSG00000097007

Experimental Data & Validation

Experimental Data

• Method: SOLUTION NMR
• Conformers Calculated: 100 
• Conformers Submitted: 20 
• Selection Criteria: target function 
• OLDERADO: 6AMW Olderado

Structure Validation

Entry History & Funding Information

Deposition Data

• Deposited Date: 2017-08-11 
• Released Date: 2017-09-27 
Deposition Author(s): Kalodimos, C.G., Rossi, P., Saleh, T.

---

Funding Organization	Location	Grant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)	United States	1R35GM122462-01

Revision History  

• Version 1.0: 2017-09-27
  Type: Initial release
  
• Version 1.1: 2017-10-11
  Changes: Database references
• Version 1.2: 2017-11-22
  Changes: Database references
• Version 1.3: 2020-01-01
  Changes: Author supporting evidence, Data collection